Electrolyte Profile, Nutritional Status and Ileostomy Formation.

July 2, 2018 updated by: ATHANASIOS MIGDANIS, Larissa University Hospital

The Effect of Ileostomy Formation on Nutritional Status and Electrolyte Profile in Rectosigmoidectomy Patients: a Prospective Randomized Trial.

One of the main reasons for hospital readmission in ileostomy patients is fluid and electrolyte abnormalities. Prospective observational studies have suggested an occurrence rate of around 20%. Due to colonic exclusion ileostomy patients lose large amounts of sodium and fluid through their stoma effluent. In addition studies have shown that ileostomy construction is a risk factor for renal impairment, occurring secondary to dehydration.

Encouraging patients to increase total fluid intake seems to be a common mistake in clinical practice as this can dilute sodium levels even more, causing greater sodium depletion. In terms of addressing the problem a few small studies have used isotonic drinks of various compositions showing increased electrolyte absorption.

Other dietary complications sometimes include hypomagnesaemia and decreased absorption of B-12 and folic acid, however due to the integrity of the small intestine other nutrient malabsorption is unlikely to occur. As far as body composition is concerned obesity has been shown to be a risk factor for peri- and postoperative complications in colorectal surgery (e.g. peristomal dermatitis, stoma stenosis and prolapse). A prospective trial examining measures that can prevent readmission for dehydration and other nutritional considerations related to this group of patients is definitely required.

Hypothesis:

The administration of an oral rehydration solution will allow a significant decrease in dehydration and electrolyte abnormality rates in patients with a temporary ileostomy.

Study Overview

Study Type

Interventional

Enrollment (Actual)

117

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Thessaly
      • Larissa, Thessaly, Greece, 41110
        • University Hospital Of Larissa

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male of female patients of more than 18 years of age
  • Patients who have undergone a rectosigmoidectomy procedure resulting or not in an ileostomy formation

Exclusion Criteria:

  • Short Bowel Syndrome
  • Diabetic ketoacidosis
  • Chronic Renal failure
  • Hepatic/Cardiac failure
  • Diabetes insipidus
  • Diuretic Medication
  • Corticosteroid Medication

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Oral rehydration solution
Patients who have undergone colorectal resection surgery resulting in an ileostomy creation
Oral rehydration solution containing: sodium chloride, sodium citrate, glucose, magnesium citrate, food additives and water.
Experimental: No intervention
Patients who have undergone colorectal resection surgery resulting in an ileostomy creation
Active Comparator: Colorectal resection without an ileostomy
Patients who have undergone colorectal resection surgery without an ileostomy creation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Serum electrolyte levels
Time Frame: up to 20-40 days postoperatively
sodium (mmol/l)
up to 20-40 days postoperatively
Serum electrolyte levels
Time Frame: up to 20-40 days postoperatively
potassium (mmol/l)
up to 20-40 days postoperatively
Serum electrolyte levels
Time Frame: up to 20-40 days postoperatively
magnesium (mg/dl)
up to 20-40 days postoperatively
Serum electrolyte levels
Time Frame: up to 20-40 days postoperatively
chloride (mmol/l)
up to 20-40 days postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical findings of dehydration
Time Frame: 20 days postoperatively, 40 days postoperatively
thirst, dizziness, lethargy, oliguria, dense urine
20 days postoperatively, 40 days postoperatively
Biochemical markers reflecting dehydration and renal function
Time Frame: 20 days postoperativey, 40 days postoperatively
Urea (mg/dl)
20 days postoperativey, 40 days postoperatively
Biochemical markers reflecting dehydration and renal function
Time Frame: 20 days postoperativey, 40 days postoperatively
Creatinine (mg/dl)
20 days postoperativey, 40 days postoperatively
Anthropometric characteristics
Time Frame: baseline, 40 days postoperatively
weight (kg)
baseline, 40 days postoperatively
Anthropometric characteristics
Time Frame: baseline, 40 days postoperatively
height (m)
baseline, 40 days postoperatively
Anthropometric characteristics
Time Frame: baseline, 40 days postoperatively
BMI (kg/m2)
baseline, 40 days postoperatively
Anthropometric characteristics
Time Frame: baseline, 40 days postoperatively
total body fat (%)
baseline, 40 days postoperatively
Nutritional Intake
Time Frame: baseline, at 20 days and 40 days postoperatively
Energy intake assessed through 24hour recalls and analyzed via nutrition analysis software
baseline, at 20 days and 40 days postoperatively
Nutritional Intake
Time Frame: baseline, at 20 days and 40 days postoperatively
Macronutrient intake assessed through 24hour recalls and analyzed via nutrition analysis software
baseline, at 20 days and 40 days postoperatively
Nutritional Intake
Time Frame: baseline, at 20 days and 40 days postoperatively
Electrolyte intake via diet assessed through 24hour recalls and analyzed via nutrition analysis software
baseline, at 20 days and 40 days postoperatively
Stoma output (ml/L)
Time Frame: baseline, at 20 days and 40 days postoperatively
baseline, at 20 days and 40 days postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: GEORGE TZOVARAS, MD, University Hopsital of Larissa
  • Principal Investigator: Georgios D Koukoulis, M.D. MSc PhD, Department of General Surgery, University Hospital of Larisa

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2013

Primary Completion (Actual)

December 1, 2017

Study Completion (Actual)

January 1, 2018

Study Registration Dates

First Submitted

December 30, 2013

First Submitted That Met QC Criteria

January 13, 2014

First Posted (Estimate)

January 15, 2014

Study Record Updates

Last Update Posted (Actual)

July 3, 2018

Last Update Submitted That Met QC Criteria

July 2, 2018

Last Verified

July 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • LarissaUH

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ileostomy

Clinical Trials on Oral Ηydration Solution

3
Subscribe